研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

谷氨酸脱氢酶1支持HIF-1α稳定性,在低氧环境下促进结肠直肠癌发生。

Glutamate dehydrogenase1 supports HIF-1α stability to promote colorectal tumorigenesis under hypoxia.

发表日期:2023 Apr 24
作者: Kunhua Hu, Yufeng Ding, Hongwen Zhu, Xiaoqian Jing, Weiling He, Hua Yu, Xiongjun Wang
来源: GENES & DEVELOPMENT

摘要:

肿瘤细胞在低氧应激下存活后获得了推动癌症进展的能力。为了探索脱氢酶对低氧响应的贡献,我们使用siRNA靶向163个脱氢酶编码基因,并发现谷氨酸脱氢酶1(GDH1)在调节结直肠癌(CRC)细胞低氧存活方面发挥了关键作用。我们观察到GDH1缺陷对CRC发生具有抑制作用,并且即使在缺氧下,也会削弱缺氧诱导因子1-alpha(HIF-1α)的稳定性。机制上,低氧引发p300的招募到GDH1,促进其在K503和K527处的乙酰化。K527处GDH1的乙酰化诱导了GDH1与EGLN1/HIF-1α的复合物的形成。相比之下,K503处GDH1的乙酰化增强了其与α-酮戊二酸(αKG)和谷氨酸的亲和力。这样看来,αKG是GDH1在缺氧状态下的产物,但缺氧刺激通过EGLN1/HIF-1α复合物逆转了GDH1的酶活性,使αKG的消耗增加,提高了HIF-1α的稳定性,从而促进了CRC的进展。临床上,低氧调节的GDH1 AcK503/527可以作为CRC进展的生物标志物,并且是CRC治疗的潜在靶点。©2023作者们。
Tumor cells surviving hypoxic stress acquire the ability to drive cancer progression. To explore the contribution of dehydrogenases to the low oxygen concentration response, we used siRNAs targeting 163 dehydrogenase-coding genes and discovered that glutamate dehydrogenase 1 (GDH1) plays a critical role in regulating colorectal cancer (CRC) cell survival under hypoxia. We observed that GDH1 deficiency had an inhibitory effect on CRC occurrence and impaired hypoxia-inducible factor 1-alpha (HIF-1α) stability even under hypoxia. Mechanistically, hypoxia triggered p300 recruitment to GDH1, promoting its acetylation at K503 and K527. GDH1 acetylation at K527 induced the formation of a GDH1 complex with EGLN1/HIF-1α; in contrast, GDH1 acetylation at K503 reinforced its affinity for α-ketoglutarate (αKG), and glutamate production. In line with this view, αKG is a product of GDH1 under normoxia, but hypoxia stimulation reversed GDH1 enzyme activity and αKG consumption by the EGLN1/HIF-1α complex, increasing HIF-1α stability and promoting CRC progression. Clinically, hypoxia-modulated GDH1 AcK503/527 can be used as a biomarker of CRC progression and is a potential target for CRC treatment.© 2023 The Authors.